(S)-N-((S)-5-amino-1-((2-amino-2-oxoethyl)amino)-1-oxopentan-2-yl)-1-((4R,7S,10S,13S,16R)-7-(2-amino-2-oxoethyl)-13-((S)-sec-butyl)-16-(4-ethoxybenzyl)-10-((R)-1-hydroxyethyl)-6,9,12,15,18-pentaoxo-1,2-dithia-5,8,11,14,17-pentaazacycloicosane-4-carbonyl)pyrrolidine-2-carboxamide acetate; Cyclic (1?5)-disulfide O-Ethyl-N-(3-mercapto-1-oxopropyl)-D-tyrosyl-L-isoleucyl-L-threonyl-L-asparaginyl-L-cysteinyl-L-prolyl-L-ornithyl-glycinamide Monoacetate; Antocile Acetate; Antocin Acetate; Antocin II Acetate; CAP 449 Acetate; CAP 476 Acetate; CAP 581 Acetate; F 314 Acetate; ORF 22164 Acetate; RW 22164 Acetate; RWJ 22164 Acetate; Tractocil Acetate; Tractocile Acetate
Atosiban Acetate is a fully characterized chemical compound used as a reference standard of API Atosiban Acetate. The standard offered is compliant with regulatory guidelines. Atosiban Acetate is used for analytical method development, method validation (AMV), and Quality Controlled (QC) applications during synthesis and formulation stages of drug development and serves as a reference standard for traceability against pharmacopeial standards (USP or EP). Axios Research products are intended for analytical purposes only and are not for human use. CAS - 914453-95-5